MAPT and supranuclear palsy, progressive, 1: Thus, in order to investigate how PSP/CBD patients could benefit from possible iron-targeting approaches, we will delve into the research regarding ferroptosis-related markers and tau in the same orderly manner as read in previous segments of the present review.